Trial Profile
A study evaluating safety, efficacy and tolerability of Tofacitinib in rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 16 Jun 2018 Results from the St. Gallen and Aarau Cohort presented at the 19th Annual Congress of the European League Against Rheumatism
- 13 Dec 2017 New trial record